Starton Therapeutics is an emerging clinical-stage biotechnology company transforming standard of care therapies with proprietary dermal delivery technology, so people with cancer can receive continuous treatment to live better, longer.
We transform FDA-approved medicines and leverage our delivery system to establish new profiles. Our platform technology allows for lower drug exposure and the potential for improved efficacy.
Starton is led by a world-class team comprised of experienced industry professionals and clinical opinion leaders. We strengthen our capabilities through collaborations with industry-leading firms. We are committed to developing bold solutions to address unmet medical needs, moving together with quality and speed to deliver on our commitment to patients.
|Access Date||Quiz Result||Score||Actions|
Please log in first before proceeding to the Sessions page
Please make sure the password is typed in ALL CAPS and includes the exclamation point. Enter the email address that you used to register for the conference.